Johnson & Johnson (LON:0R34)

Market Cap	318.94B
Revenue (ttm)	66.08B
Net Income (ttm)	16.52B
Shares Out	n/a
EPS (ttm)	6.81
PE Ratio	19.30
Forward PE	16.40
Dividend	3.87 (2.16%)
Ex-Dividend Date	May 27, 2025

Volume	7,663
Average Volume	6,273
Open	179.27
Previous Close	179.93
Day's Range	177.50 - 181.09
52-Week Range	139.94 - 181.09
Beta	n/a
RSI	74.01
Earnings Date	Oct 14, 2025

About Johnson & Johnson

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizo...

• Industry: Pharmaceutical Preparations
• Founded: 1886
• Employees: 138,100
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0R34

Financial Performance

In 2024, Johnson & Johnson's revenue was $88.82 billion, an increase of 4.30% compared to the previous year's $85.16 billion. Earnings were $14.07 billion, a decrease of -59.99%.

Financial numbers in USD